IL31 and allergic disease: It would also be interesting to evaluate whether SLA could modulate different axes of the immune response involved in allergies, autoimmune disease or pathogenesis of viral infections (e.g., Treg, Th17, and IL-31/33) when administered alone or in combination with vitamin D, which has been shown to suppress mast cell activation in allergic manifestations through regulatory T cells [37,38].